The FDA is looking to get thrifty with its approved drugs. | The framework would leverage existing safety data on approved drugs to provide new options to patients with unmet medical needs, the FDA explained.
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
Targeted protein degradation is changing how drug discovery teams think about disease biology. For many years, small molecule…
With the recent launches of Novo Nordisk’s Wegovy pill and Eli Lilly’s Foundayo, the obesity market has started to shift toward…
Strengthening core CDO values for cell line development | Strengthening core CDO values for cell line development
The companies developing Ebvallo reached an agreement with the FDA to address its main reason for rejecting the drug.
Secret drug pricing deals, a virtual AI cancer clinic, and other biotech news from The Readout
With the FDA now rudderless following the revelation that commissioner Marty Makary, M.D., is stepping down, voices across…
Billions In Prescriptions Go Unfilled. This Startup Is Using AI To Fix That.
